Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for chemotherapy-induced peripheral neuropathy
IRCT20160310026998N12Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Memantine with Placebo (2 arms). Primary endpoint: Chemotherapy induced peripheral neuropathic pain severity. Started Aug 2020; status: completed.
02
Drugs
memantine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20160310026998N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160310026998N12.